Michael Banov

1.5k total citations
15 papers, 1.1k citations indexed

About

Michael Banov is a scholar working on Psychiatry and Mental health, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael Banov has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael Banov's work include Bipolar Disorder and Treatment (8 papers), Schizophrenia research and treatment (7 papers) and Treatment of Major Depression (5 papers). Michael Banov is often cited by papers focused on Bipolar Disorder and Treatment (8 papers), Schizophrenia research and treatment (7 papers) and Treatment of Major Depression (5 papers). Michael Banov collaborates with scholars based in United States, Singapore and Romania. Michael Banov's co-authors include Mauricio Tohen, Carlos A. Zarate, J F Rosenbaum, Beny Lafer, Andrej Stoll, A Thibault, Charles L. Bowden, Holland C. Detke, Richard C. Risser and Roy H. Perlis and has published in prestigious journals such as American Journal of Psychiatry, Journal of Affective Disorders and The Journal of Clinical Psychiatry.

In The Last Decade

Michael Banov

14 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Banov United States	12	862	253	114	105	92	15	1.1k
WFSBP Task Force on Treatment Guide United States	8	1.1k 1.2×	408 1.6×	110 1.0×	29 0.3×	274 3.0×	8	1.4k
Teresa Huggins United States	10	332 0.4×	122 0.5×	54 0.5×	97 0.9×	62 0.7×	13	619
T A Ketter United States	11	680 0.8×	101 0.4×	234 2.1×	41 0.4×	89 1.0×	15	920
Gabriela Cora‐Locatelli United States	9	469 0.5×	66 0.3×	184 1.6×	128 1.2×	264 2.9×	13	903
Lorenzo Lattanzi Italy	14	578 0.7×	286 1.1×	20 0.2×	38 0.4×	167 1.8×	44	936
Brett D. M. Jones Canada	15	218 0.3×	147 0.6×	20 0.2×	71 0.7×	117 1.3×	51	643
T. Jacobs United States	9	1.0k 1.2×	374 1.5×	146 1.3×	8 0.1×	155 1.7×	23	1.2k
P G Janicak United States	8	341 0.4×	126 0.5×	98 0.9×	33 0.3×	60 0.7×	10	455
Annalisa Anastasia Italy	15	336 0.4×	148 0.6×	35 0.3×	121 1.2×	231 2.5×	31	712
Max Fink United States	10	359 0.4×	271 1.1×	28 0.2×	54 0.5×	61 0.7×	14	699

Countries citing papers authored by Michael Banov

Since Specialization

Citations

This map shows the geographic impact of Michael Banov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Banov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Banov more than expected).

Fields of papers citing papers by Michael Banov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Banov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Banov. The network helps show where Michael Banov may publish in the future.

Co-authorship network of co-authors of Michael Banov

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Banov. A scholar is included among the top collaborators of Michael Banov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Banov. Michael Banov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Banov, Michael, et al.. (2021). Switching to Intranasal Esketamine Maintains the Antidepressant Response to Intravenous Racemic Ketamine Administration. Journal of Clinical Psychopharmacology. 41(5). 594–599. 3 indexed citations

Banov, Michael, et al.. (2019). Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature. CNS Spectrums. 25(3). 331–342. 28 indexed citations

Banov, Michael. (2018). Management of Depression, Part 2: Treatment Options. 1 indexed citations

Aaronson, Scott T., Linda L. Carpenter, Charles R. Conway, et al.. (2012). Vagus Nerve Stimulation Therapy Randomized to Different Amounts of Electrical Charge for Treatment-Resistant Depression: Acute and Chronic Effects. Brain stimulation. 6(4). 631–640. 126 indexed citations

Banov, Michael, David E. Adson, Catherine Datto, et al.. (2010). Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study☆. Journal of Affective Disorders. 128(1-2). 83–94. 62 indexed citations

Tohen, Mauricio, Eduard Vieta, Guy M. Goodwin, et al.. (2008). Olanzapine Versus Divalproex Versus Placebo in the Treatment of Mild to Moderate Mania. The Journal of Clinical Psychiatry. 69(11). 1776–1789. 66 indexed citations

Rickels, Karl, Sanjay J. Mathew, Michael Banov, et al.. (2008). Effects of PRX-00023, a Novel, Selective Serotonin 1A Receptor Agonist on Measures of Anxiety and Depression in Generalized Anxiety Disorder. Journal of Clinical Psychopharmacology. 28(2). 235–239. 18 indexed citations

Tohen, Mauricio, Joseph R. Calabrese, Roy H. Perlis, et al.. (2006). Randomized, Placebo-Controlled Trial of Olanzapine as Maintenance Therapy in Patients With Bipolar I Disorder Responding to Acute Treatment With Olanzapine. American Journal of Psychiatry. 163(2). 247–256. 221 indexed citations

Green, A. I., Jayendra K. Patel, Michael Banov, et al.. (2000). Clozapine in the Treatment of Refractory Psychotic Mania. American Journal of Psychiatry. 157(6). 982–986. 89 indexed citations

10.

Pillay, Srinivasan S., Andrew L. Stoll, Mauricio Tohen, et al.. (1996). EEG Abnormalities Before Clozapine Therapy Predict a Good Clinical Response to Clozapine. Annals of Clinical Psychiatry. 8(1). 1–5. 22 indexed citations

11.

Zarate, Carlos A., et al.. (1995). Is clozapine a mood stabilizer?. PubMed. 56(3). 108–12. 93 indexed citations

12.

Stoll, Andrew L., Michael Banov, P. Mayer, et al.. (1994). Neurologic Factors Predict a Favorable Valproate. Journal of Clinical Psychopharmacology. 14(5). 311???313–311???313. 34 indexed citations

13.

Banov, Michael, Carlos A. Zarate, Mauricio Tohen, et al.. (1994). Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up.. PubMed. 55(7). 295–300. 92 indexed citations

14.

Lafer, Beny, Andrej Stoll, Michael Banov, et al.. (1994). A double-blind trial of bupropion versus desipramine for bipolar depression.. PubMed. 55(9). 391–3. 220 indexed citations

15.

Banov, Michael, et al.. (1993). A new identity for misidentification syndromes. Comprehensive Psychiatry. 34(6). 414–417. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact